Skip to Content

MCR 314 (Lamivudine 300 mg)

Pill with imprint MCR 314 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Appco Pharma LLC.

Lamivudine is used in the treatment of hepatitis b; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MCR 314

Lamivudine

Imprint:
MCR 314
Strength:
300 mg
Color:
Gray
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Appco Pharma LLC
National Drug Code (NDC):
55801-0314

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide